Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Healthy human immune system cells can respond to HIV-1 – findings offer hope for vaccine against AIDS

18.05.2006
AIDS patients’ failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought. A study published today in the open access journal Medical Immunology shows that cultured immune system cells taken from healthy individuals recognise and respond to HIV-1 proteins. Cells taken from infected individuals, however, are much less responsive to the virus.

These findings need to be reproduced in vivo, but they do offer new hope for a vaccine against AIDS. Exposing healthy individuals to HIV-1 proteins before they are infected with the virus might train their immune system to respond to the virus and prevent them from developing AIDS.

The study was conducted by Pedro Reche and Derin Keskin from the Dana-Farber Cancer Institute, Boston, USA and other colleagues from Dana-Farber and Harvard Medical School, Boston, USA. They used bioinformatics techniques to predict which HIV-1 protein fragments – or ‘epitopes’ - were likely to trigger a response from immune system cells called cytotoxic T lymphocytes. They identified 37 epitopes. Reche, Keskin et al. then predicted which of these 37 epitopes were likely to be recognised by most people’s immune systems, taking into account genetic differences in immune system genes, called HLA genes, depending on ethnic origin. They identified 25 epitopes, which they combined into five pools with which to test immune responses. They predicted that only 5 of these epitopes would be recognised by over 95% of people’s immune systems.

The authors exposed cultured lymphocytes from HIV-1 infected patients to the epitope pools, and repeated the experiment with cultured lymphocytes from healthy donors. They assessed the response to the epitopes by measuring the levels of interferon gamma (IFN gamma) produced by the cultured T lymphocytes – IFN gamma is produced by responsive T lymphocytes upon activation by pathogenic or viral proteins and helps to destroy infectious organisms.

Reche, Keskin et al.’ s results show that only a small proportion of cells from HIV-1infected patients recognised the epitopes and mounted an adequate immune response: cells from only 31-45% of patients produced IFN gamma, and in small quantities. By contrast, cells from all healthy donors responded and produced IFN gamma in large quantities. The authors also demonstrate that these exposed lymphocytes from uninfected individuals could kill HIV-1 infected cells.

Juliette Savin | alfa
Further information:
http://www.biomedcentral.com

More articles from Life Sciences:

nachricht New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)

nachricht Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>